A multicenter, randomized, double-blind, placebo-controlled study of the hemodynamic effects of rolofylline injectable emulsion in the treatment of patients with heart failure

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002209-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objectives of this study are to estimate the effects of rolofylline, alone in addition to loop diuretic therapy, on pulmonary capillary wedge pressure, as well as other hemodynamic parameters, and to estimate the effects of rolofylline on diuresis and natriuresis in patients with heart failure and renal impairment.


Critère d'inclusion

  • Patients hospitalised with heart failure, volume overload and renal impairment, who require loop diuretic therapy and hemodynamic monitoring for clinical reasons